Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (TSX:RY)

175.84 UNCHANGED
Streaming Delayed Price Updated: 4:18 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Royal Bank of Canada

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Why GitLab Stock Slumped by Nearly 5% on Monday
Via The Motley Fool
Topics World Trade
Exposures Tariff
RBC Bearings Can Defy Macro Headwinds, Says Analyst, On Aerospace Strength, Tariff Resilience
Truist Securities analyst revised price forecast on RBC Bearings to $405, keeping Buy rating. Q4 EPS beat, sales missed. Q1 sales expected to be $424M-$434M. 
Via Benzinga
Topics Earnings
Exposures Financial
Why Fluence Energy Stock Was Flying High This Week
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
RBC Bearings (NYSE:RBC) Reports Sales Below Analyst Estimates In Q1 Earnings
Bearings manufacturer RBC Bearings (NYSE:RBC) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.8% year on year to $437.7 million. Next quarter’s revenue guidance of $429 million... 
Via StockStory
RBC Bearings Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
What's Next: RBC Bearings's Earnings Preview
Via Benzinga
RBC Bearings Earnings: What To Look For From RBC
Bearings manufacturer RBC Bearings (NYSE:RBC) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
Owens Corning’s Board Clears 12M Share Repurchase Ahead Of Investor Day — Stock Unmoved Pre-Market
The announcement follows a slew of price cuts from analysts after the company’s second-quarter outlook disappointed Wall Street. 
Via Stocktwits
Topics World Trade
Exposures Tariff
UnitedHealth Regains Retail Confidence Amid After-Hours Rebound: Analysts React To CEO Exit, FY25 Guidance Suspension
At least two research firms said the stock may have bottomed following the “latest in a string of setbacks.” 
Via Stocktwits
1 Mid-Cap Stock to Target This Week and 2 to Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Digital Ad Firm Trade Desk Rebounds With Better-Than-Expected Earnings
Trade Desk stock rose after the digital advertising firm rebounded with a better-than-expected Q1 after lowering expectations in early 2025. 
Via Investor's Business Daily
Wall Street Remains Overwhelmingly Bullish About This 9.2%-Yielding Dividend Stock Despite Economic Uncertainty and Volatility
Via The Motley Fool
Topics Economy Government World Trade
Exposures Interest Rates Political Tariff
2 Popular AI Stock to Sell Before They Fall 64% and 67%, According to Certain Wall Street Analysts
Via The Motley Fool
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
$1000 Invested In RBC Bearings 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Palantir Stock Plummets As Analysts Flag Valuation Risks Despite Q1 Revenue Beat
Analysts warn that while Palantir's execution is impressive, concerns remain that its stock trades at a valuation difficult to justify without further acceleration. 
Via Stocktwits
Topics Artificial Intelligence Earnings Government
Exposures Artificial Intelligence Financial Political
Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug
The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands. 
Via Investor's Business Daily
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
Exposures Intellectual Property Political
Analysts Still Like Chevron, Cite Strong FCF & Balance Sheet As Key Amid OPEC And Recession Fears
B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also... 
Via Benzinga
Topics Economy
Exposures Economy
Diamondback Energy Q1 Preview: Investors Eyeing Production Forecast Amid Oil Price Drop, Retail’s Divided
Wall Street expects the oil and gas producer to post adjusted earnings of $4.20 per share on revenue of $3.75 billion. 
Via Stocktwits
Topics World Trade
Exposures Tariff
2 Profitable Stocks with Promising Prospects and 1 to Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Cybersecurity Stocks: Artificial Intelligence Dominates RSA Conference But Monetization Still In Question
The RSA conference this week didn't deliver much breaking news on cybersecurity stocks but Wall Street analysts came away upbeat on industry trends. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Cash-Producing Stocks with Competitive Advantages and 1 to Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Price Over Earnings Overview: RBC Bearings
Via Benzinga
Palantir's Government, Commercial Business Trends Eyed In Q1 Earnings
Palantir reports Q1 earnings on Monday, the data analytics software maker's government and commercial businesses will again be in focus. 
Via Investor's Business Daily
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today
Via Benzinga
Visa's Q2 Results Reflect Steady US Spending Despite Market Uncertainty: Analyst Highlights Strength In Payment Volumes
Visa gains after RBC's Perlin highlights strong Q2 results, steady U.S. spending, and a $30B buyback plan. 
Via Benzinga
BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
The company sells a rival to Pfizer' heart treatment, Vyndaqel. Sales smashed expectations in its first quarter on the market. 
Via Investor's Business Daily
1 Industrials Stock to Consider Right Now and 2 to Approach with Caution
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence... 
Via StockStory
Topics Stocks
Exposures US Equities
DoorDash's Deliveroo Offer Seen As 'Meaningfully Expanding' Global Reach
DoorDash stock analysts were mostly positive on the company's offer to acquire U.K.-focused food delivery firm Deliveroo. 
Via Investor's Business Daily
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
The companies are working on treatments for a form of bladder cancer. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.